Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control study (2023)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s41512-023-00155-z
Publication URI: http://dx.doi.org/10.1186/s41512-023-00155-z
Type: Journal Article/Review
Parent Publication: Diagnostic and Prognostic Research
Issue: 1